 I'm Jerry Willis, and this is the Fox Business Report. Eli Lilly will buy biopharmaceutical company Morphic Holding for $3.2 billion. The sale is expected to be completed in the third quarter. Morphic is leading the way in developing treatment for serious chronic diseases.